Improved collection of mobilized CD34+ hematopoietic progenitor cells by a novel automated leukapheresis system

Transfusion

Volumn 39, Issue 1, 1999, Pages 48-55

  Ravagnani, F ^a   Siena, S ^a   De Reys, S ^a   Di Nicola, M ^a   Notti, P ^a   Giardini, R ^a   Bregni, M ^a   Matteucci, P ^a   Gianni, A M ^a   Pellegris, G ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CD34 ANTIGEN; CYCLOPHOSPHAMIDE; ETOPOSIDE; GRANULOCYTE COLONY STIMULATING FACTOR; IFOSFAMIDE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ADULT; ARTICLE; AUTOMATION; COMPUTER PROGRAM; DEVICE; ERYTHROCYTE; FEMALE; HEMATOPOIETIC STEM CELL; HUMAN; LEUKAPHERESIS; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; SUBCUTANEOUS DRUG ADMINISTRATION; THROMBOCYTE;

EID: 0032954578     PISSN: 00411132     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1537-2995.1999.39199116894.x     Document Type: Article

References (32)

1. To LB, Haylock DN, Simmons PJ, Juttner CA. The biology and clinical uses of blood stem cells. Blood 1997;89:2233-58.
2. Gratwohl A, Hermans J, Baldomero H. Blood and marrow transplantation activity in Europe 1995. European Group for Blood and Marrow Transplantation (EBMT). Bone Marrow Transplant 1997;19:407-19.
3. Schreiner T, Maccari B, Erne E, et al. Highly effective CD34+ selection of granulocyte colony-stimulating factor-mobilized allogeneic peripheral blood progenitor cells (letter). Blood 1996;88:1517-8.
4. Gianni AM, Bregni M, Siena S, et al. High-dose chemotherapy and autologous bone marrow transplantation compared with MACOP-B in aggressive B-cell lymphoma. N Engl J Med 1997;336:1290-7.
5. Gianni AM, Siena S, Bregni M, et al. Efficacy, toxicity, and applicability of high-dose sequential chemotherapy as adjuvant treatment in operable breast cancer with 10 or more involved axillary nodes: five-year results. J Clin Oncol 1997;15:2312-21.
6. Ravagnani F, Notti P, Siena S, et al. Clinical application of growth factors for collection of circulating hematopoietic progenitors in breast cancer patients treated with high-dose cyclophosphamide. Int J Artif Organs 1993;16(Suppl 5):35-8.
7. Smolowicz AG, Villman K, Tidefelt U. Large-volume apheresis for the harvest of peripheral blood progenitor cells for autologous transplantation. Transfusion 1997;37:188-92.
8. Siena S, Bregni M, Brando B, et al. Flow cytometry to estimate circulating hematopoietic progenitors for autologous transplantation: comparative analysis of different CD34 monoclonal antibodies. Haematologica 1991;76:330-3.
9. Weaver CH, Hazelton B, Birch R, et al. An analysis of engraftment kinetics as a function of the CD34 content of peripheral blood progenitor cell collections in 692 patients after the administration of myeloablative chemotherapy. Blood 1995;86:3961-9.
10. Aversa F, Tabilio A, Terenzi A, et al. Successful engraftment of T-cell-depleted haploidentical "three-loci" incompatible transplants in leukemia patients by addition of recombinant human granulocyte colony-stimulating factor-mobilized peripheral blood progenitor cells to bone marrow inoculum. Blood 1994;84:3948-55.
11. Reisner Y, Martelli MF. Bone marrow transplantation across HLA barriers by increasing the number of transplanted cells. Immunol Today 1995;16:437-40.
12. Siena S, Bregni M, Di Nicola M, et al. Durability of hematopoiesis following autografting with peripheral blood hematopoietic progenitors. Ann Oncol 1994;5:935-41.
13. Kiss JE, Rybka WB, Winkelstein A, et al. Relationship of CD34+ cell dose to early and late hematopoiesis following autologous peripheral blood stem cell transplantation. Bone Marrow Transplant 1997;19:303-10.
14. Baars JW, Nooyen WJ, van Beers C, et al. Adjustment of the interface detector (location 71) to the absolute number of mononuclear cells in the peripheral blood: no improvement of the collection efficiency of the Fenwal CS3000 plus during progenitor cell harvests. J Clin Apheresis 1997;12:68-73.
15. Ravagnani F, Siena S, Bregni M, et al. Large-scale collection of circulating haematopoietic progenitors in cancer patients treated with high-dose cyclophosphamide and recombinant human GM-CSF. Eur J Cancer 1990;26:562-4.
16. Di Nicola M, Siena S, Bregni M, et al. Large-scale enrichment of mobilized CD34+ peripheral blood hematopoietic progenitors by removal of nylon wool-adherent mature cells. Bone Marrow Transplant 1994;14:863-9, erratum published Bone Marrow Transplant Aug 1995;16:327.
17. Bensinger W, Appelbaum F, Rowley S, et al. Factors that influence collection and engraftment of autologous peripheral-blood stem cells. J Clin Oncol 1995;13:2547-55.
18. Schwella N, Siegert W, Beyer J, et al. Autografting with blood progenitor cells: predictive value of preapheresis blood cell counts on progenitor cell harvest and correlation of the reinfused cell dose with hematopoietic reconstitution. Ann Hematol 1995;71:227-34.
19. Schwella N, Beyer J, Schwaner I, et al. Impact of preleukapheresis cell counts on collection results and correlation of progenitor-cell dose with engraftment after high-dose chemotherapy in patients with germ cell cancer. J Clin Oncol 1996;14:1114-21.
20. Armitage S, Hargreaves R, Samson D, et al. CD34 counts to predict the adequate collection of peripheral blood progenitor cells. Bone Marrow Transplant 1997;20:587-91.
21. Jestice HK, Boraks P, Scott MA, et al. Improved yield of peripheral blood progenitor cells on the COBE Spectra. Bone Marrow Transplant 1996;18:597-601.
22. DeGasperi D, Lebrun P, Gregoire F, et al. High-volume (15 L) peripheral blood stem cell apheresis does not impair significantly the yield of CD34+ stem cell collected (abstracted). Bone Marrow Transplant 1997;19:S236.
23. Grima K, Preti RA, Sheehy J, et al. An evaluation of the Fresenius AS104 apheresis device for the collection of peripheral blood stem cells (PBSC). J Clin Apheresis 1997;12:35-40.
24. Micléa JM, Makki J, Gouley C, et al. Enhancement of the COBE Spectra AutoPBSC™ system to collect PBPC: reduced neutrophil and platelet contamination and collection volume (abstract). Blood 1997;90:334b.
25. Schoneman F, Claise C. Comparison of four methods for collection of peripheral blood stem cell in 24 patients. J Clin Apheresis 1996;11:119-123.
26. Owen HG, Brecher ME. Paired randomized comparative study of PBSC collection. J Clin Apheresis 1997;12:29-32.
27. Bellavita P, Celega E, Poma R. Comparison of performance of six different cell separators in collecting peripheral blood mononuclear cells. Transfus Sci 1997;18:215-21.
28. Morton JAP, Baker DP, Hutchins CJ, Durrant STS. The COBE Spectra cell separator is more effective than the Haemonetics MCS-3P cell separator for peripheral blood progenitor cell harvest after mobilization with cyclophosphamide and filgrastim. Transfusion 1997;37:631-3.
29. Mehta J, Powles R, Treleaven J, et al. Prospective, concurrent comparison of the Cobe Spectra and Haemonetics MCS-3P cell separators for leukapheresis after high-dose filgrastim in patients with hematologic malignancies. J Clin Apheresis 1997;12:63-7.
30. Bambi F, Faulkner LB, Azzari C, et al. Pediatric peripheral blood progenitor cell collection: Haemonetics MCS 3P versus COBE Spectra versus Fresenius AS104. Transfusion 1998;38:70-4.
31. Dzieczkowski IS, McGonigal M, Cook J, et al. A comparison of peripheral blood stem cell apheresis using the Fenwal CS 3000plus and COBE Spectra. Transfus Sci 1995;16:71-7.
32. Gluck S. Autologous transplantation for patients with advanced breast cancer with emphasis on bony metastasis. Can J Oncol 1995;5:58-62.